Miliary tuberculosis following negative latent tuberculosis infection screening prior to tumor necrosis factor-α antagonists: implications for management?

Journal Contribution ResearchOnline@JCU
Teh, Benjamin W.;Street, Alan C.;McBryde, Emma S.;Denholm, Justin T.
Emma McBryde
Abstract

[Extract] Tumor necrosis factor-α (TNF-α) antagonists are effective treatments for inflammatory disorders but are associated with an increased risk of infections including reactivation of latent tuberculosis infection (LTBI). We describe a patient who developed miliary TB as a complication of TNF-α antagonist therapy despite negative pretherapy screening for LTBI.

Journal

JOURNAL OF RHEUMATOLOGY

Publication Name

N/A

Volume

39

ISBN/ISSN

1499-2752

Edition

N/A

Issue

6

Pages Count

2

Location

N/A

Publisher

Journal of Rheumatology Publishing

Publisher Url

N/A

Publisher Location

N/A

Publish Date

N/A

Url

N/A

Date

N/A

EISSN

N/A

DOI

10.3899/jrheum.111577